Effect of Serum Albumin Levels in Patients With Heart Failure With Preserved Ejection Fraction (from the TOPCAT Trial)
Authors:
- 1 February 2020
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 125 (4) , 575-582
Abstract
No abstract availableKeywords
Funding Information
- Bristol-Myers Squibb
- National Institutes of Health
This publication has 24 references indexed in Scilit:
- Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fractionAmerican Heart Journal, 2011
- Hypoalbuminaemia and Incident Heart Failure in Older AdultsEuropean Journal of Heart Failure, 2011
- Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection FractionCirculation: Heart Failure, 2011
- Serum albumin and mortality in acutely decompensated heart failureAmerican Heart Journal, 2010
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseGut, 2010
- Inflammatory Markers and Incident Heart Failure Risk in Older AdultsJACC, 2010
- Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health StudyNephrology Dialysis Transplantation, 2009
- The NAFLD fibrosis scoreHepatology, 2007
- Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patientsKidney International, 2004
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999